AMWL
American Well Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+15/100
Last price
12.27
▼ 0.45 (3.54%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
12.76
Prev close
12.72
Day high
12.83
Day low
12.23
Volume
91.09K
Market cap
$208.70M
P/E (TTM)
—
52W range
3.71 – 14.19
Day trading desk
Gap from prior close
+0.31%
Prior close 12.72
VWAP
12.32
-0.37% from price
Relative volume
1.38×
Normal
Session range
5.34%
12.18 – 12.83
Position in range
14%
Near session low
ATR (14D)
0.69
5.66% of price
Prior day high
12.85
PDH
Prior day low
12.00
PDL
Bid / ask spread
—
Quote not published
Session volume
172.44K
Avg 125.14K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.62%
-8.6%
1M
-5.54%
-6.7%
3M
+41.52%
+37.0%
6M
+129.78%
+111.6%
YTD
+149.90%
+135.6%
1Y
+93.84%
+77.4%
3Y
-47.56%
-129.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AMWL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+28.95K
Net buying
Buy transactions
7
87.68K shares
Sell transactions
11
58.72K shares
Net transactions
+18
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
776.79K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 1, 26 | HIRSCHHORN MARK J Chief Financial Officer |
SELL | 10.75K | $126.86K | Direct |
| Sep 1, 26 | MCNEICE PAUL FRANCIS Officer |
SELL | 112 | $1.32K | Direct |
| Sep 1, 26 | GOTLIB PHYLLIS Officer |
SELL | 3.57K | $42.16K | Direct |
| Jul 1, 26 | HIRSCHHORN MARK J Chief Financial Officer |
SELL | 4.30K | $40.11K | Direct |
| Jul 1, 26 | MCNEICE PAUL FRANCIS Officer |
SELL | 653 | $6.09K | Direct |
| Jul 1, 26 | GOTLIB PHYLLIS Officer |
SELL | 6.68K | $62.30K | Direct |
| Jul 1, 26 | ZAMANSKY DMITRY Chief Technology Officer |
SELL | 8.46K | $78.93K | Direct |
| Jun 16, 26 | JACKSON DEBORAH C Director |
STOCK | 14.50K | $0 | Direct |
| Jun 16, 26 | ROSS DEREK Director |
STOCK | 14.50K | $0 | Direct |
| Jun 16, 26 | SCHLEGEL STEPHEN J Director |
STOCK | 14.50K | $0 | Direct |
| Jun 16, 26 | COSGROVE DELOS M Director |
STOCK | 14.50K | $0 | Direct |
| Jun 16, 26 | WEBB ROBERT THOMAS Director |
STOCK | 14.50K | $0 | Direct |
| Jun 16, 26 | GOLDWASSER RIVKA Director |
STOCK | 14.50K | $0 | Direct |
| Jun 11, 26 | SCHLEGEL STEPHEN J Director |
SELL | 9.75K | $85.45K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
GOLDWASSER RIVKA |
Director | 105.86K | Stock Award(Grant) |
GOTLIB PHYLLIS |
Officer | 264.10K | Sale |
HIRSCHHORN MARK J |
Chief Financial Officer | 228.19K | Sale |
KNIGHT KURT |
Chief Operating Officer | 142.21K | Sale |
PAUNOVICH VUKASIN |
Officer | 116.12K | Sale |
SCHOENBERG IDO |
Chief Executive Officer | 277.92K | Purchase |
SCHOENBERG ROY |
Officer and Director | 133.30K | Stock Award(Grant) |
WEBB ROBERT THOMAS |
Director | 72.56K | Stock Award(Grant) |
WEILER KATHY JOHNSON |
Officer | 180.59K | Sale |
ZAMANSKY DMITRY |
Chief Technology Officer | 232.62K | Sale |
Fundamentals
Market cap$208.70M
Enterprise value$28.82M
Revenue (TTM)$218.52M
Gross profit$114.91M
EBITDA$-39.89M
Net income$-78.11M
EPS (TTM)$-4.77
Free cash flow$3.86M
Total cash$195.95M
Total debt$2.98M
Book value / share$13.07
Shares outstanding15.36M
Float11.93M
Short % of float1.09%
Dividend yield0.00%
Beta (5Y)1.68
Valuation & profitability ratios
Trailing P/E—
Forward P/E-7.77
PEG ratio—
Price / sales—
Price / book0.94
EV / revenue0.13
EV / EBITDA-0.72
Gross margin52.58%
Operating margin-19.59%
Profit margin-35.75%
Return on equity-29.12%
Return on assets-12.65%
Debt / equity1.27
Current ratio2.90
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $249.32M | $254.36M | $259.05M | $277.19M | -2.0% |
| Operating revenue | $226.69M | $232.00M | $231.85M | $245.27M | -2.3% |
| Cost of revenue | $116.47M | $155.41M | $164.29M | $160.42M | -25.1% |
| Gross profit | $132.86M | $98.95M | $94.76M | $116.77M | +34.3% |
| Research & development | $72.86M | $86.06M | $105.83M | $138.49M | -15.3% |
| Selling, general & admin | $131.31M | $197.45M | $213.10M | $227.98M | -33.5% |
| Total operating expense | $238.13M | $316.49M | $350.42M | $392.62M | -24.8% |
| Operating income | -$105.27M | -$217.53M | -$255.66M | -$275.85M | +51.6% |
| Net interest income | $3.80M | $10.76M | $19.42M | $6.12M | -64.6% |
| Pre-tax income | -$92.84M | -$206.78M | -$672.72M | -$269.73M | +55.1% |
| Tax provision | $434.00K | $2.75M | $3.86M | $64.00K | -84.2% |
| Net income | -$95.70M | -$208.14M | -$675.16M | -$270.43M | +54.0% |
| Net income to common | -$95.70M | -$208.14M | -$675.16M | -$270.43M | +54.0% |
| Basic EPS | -5.96 | -13.88 | -47.60 | -19.80 | +57.1% |
| Diluted EPS | -5.96 | -13.88 | -47.60 | -19.80 | +57.1% |
| EBIT | -$105.27M | -$217.53M | -$255.66M | -$275.85M | +51.6% |
| EBITDA | -$71.31M | -$184.56M | -$224.15M | -$249.69M | +61.4% |
| Basic shares | 16.05M | 15.00M | 14.21M | 13.71M | +7.0% |
| Diluted shares | 16.05M | 15.00M | 14.21M | 13.71M | +7.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $182.33M | $228.32M | $372.04M | $538.55M | -20.1% |
| Cash & short-term investments | $182.33M | $228.32M | $372.04M | $538.55M | -20.1% |
| Accounts receivable | $49.69M | $71.89M | $54.15M | $58.37M | -30.9% |
| Inventory | $1.19M | $2.86M | $6.65M | $8.74M | -58.5% |
| Total current assets | $246.68M | $316.99M | $449.58M | $626.62M | -22.2% |
| Property, plant & equipment | $4.16M | $7.58M | $11.03M | $14.52M | -45.2% |
| Goodwill & intangibles | $66.07M | $101.54M | $120.25M | $570.26M | -34.9% |
| Total assets | $323.79M | $435.97M | $589.71M | $1.22B | -25.7% |
| Total current liabilities | $73.21M | $111.26M | $93.80M | $114.06M | -34.2% |
| Total debt | $4.52M | $8.20M | $11.79M | $14.84M | -44.8% |
| Total liabilities | $76.00M | $119.72M | $109.52M | $133.71M | -36.5% |
| Retained earnings | -$2.06B | -$1.97B | -$1.76B | -$1.08B | -4.9% |
| Shareholder equity | $235.58M | $304.77M | $464.22M | $1.06B | -22.7% |
| Working capital | $173.47M | $205.73M | $355.79M | $512.56M | -15.7% |
| Net tangible assets | $169.51M | $203.23M | $343.97M | $493.62M | -16.6% |
| Shares issued | 16.43M | 15.57M | 14.42M | 13.86M | +5.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$94.97M | -$212.64M | -$679.17M | -$272.07M | +55.3% |
| Depreciation & amortisation | $33.96M | $32.97M | $31.51M | $26.17M | +3.0% |
| Stock-based compensation | $22.01M | $47.54M | $72.25M | $67.67M | -53.7% |
| Change in working capital | -$26.80M | -$9.98M | -$15.51M | -$28.10M | -168.5% |
| Operating cash flow | -$65.95M | -$127.34M | -$148.34M | -$192.32M | +48.2% |
| Capital expenditure | -$21.00K | -$15.22M | -$15.25M | -$10.45M | +99.9% |
| Investing cash flow | $17.10M | -$18.65M | -$19.17M | -$11.63M | +191.7% |
| Share buybacks | -$4.00K | -$3.00K | -$586.00K | -$360.00K | -33.3% |
| Financing cash flow | $840.00K | $1.38M | $2.15M | -$3.61M | -39.2% |
| Free cash flow | -$65.97M | -$142.56M | -$163.59M | -$202.77M | +53.7% |
| End cash position | $183.12M | $229.11M | $372.83M | $539.34M | -20.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $52.05M | $54.88M | $55.31M | $56.29M | $70.90M | -5.2% |
| Operating revenue | $50.13M | $53.79M | $52.55M | $52.09M | $63.21M | -6.8% |
| Cost of revenue | $24.49M | $26.92M | $26.97M | $26.78M | $31.14M | -9.0% |
| Gross profit | $27.56M | $27.96M | $28.34M | $29.51M | $39.76M | -1.4% |
| Research & development | $10.35M | $12.38M | $13.94M | $18.58M | $18.24M | -16.4% |
| Selling, general & admin | $19.75M | $25.45M | $31.05M | $30.81M | $33.67M | -22.4% |
| Total operating expense | $37.12M | $45.39M | $53.49M | $58.84M | $60.13M | -18.2% |
| Operating income | -$9.56M | -$17.42M | -$25.15M | -$29.33M | -$20.38M | +45.2% |
| Net interest income | -$617.00K | $313.00K | -$368.00K | $638.00K | $845.00K | -297.1% |
| Pre-tax income | -$10.17M | -$10.08M | -$25.60M | -$30.69M | -$19.53M | -0.9% |
| Tax provision | -$548.00K | $217.00K | -$626.00K | $1.22M | -$725.00K | -352.5% |
| Net income | -$9.93M | -$10.89M | -$24.92M | -$32.38M | -$19.70M | +8.8% |
| Net income to common | -$9.93M | -$10.89M | -$24.92M | -$32.38M | -$19.70M | +8.8% |
| Basic EPS | -0.59 | -0.66 | -1.52 | -2.00 | -1.24 | +10.6% |
| Diluted EPS | -0.59 | -0.66 | -1.52 | -2.00 | -1.24 | +10.6% |
| EBIT | -$9.56M | -$17.42M | -$25.15M | -$29.33M | -$20.38M | +45.2% |
| EBITDA | -$2.54M | -$9.83M | -$16.66M | -$19.89M | -$12.15M | +74.2% |
| Basic shares | 16.76M | 16.59M | 16.40M | 16.21M | 15.89M | +1.0% |
| Diluted shares | 16.76M | 16.59M | 16.40M | 16.21M | 15.89M | +1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $195.95M | $179.21M | $182.33M | $200.89M | $219.07M | +9.3% |
| Cash & short-term investments | $195.95M | $179.21M | $182.33M | $200.89M | $219.07M | +9.3% |
| Accounts receivable | $52.61M | $57.09M | $49.69M | $55.58M | $53.56M | -7.9% |
| Inventory | $964.00K | $1.15M | $1.19M | $1.82M | $2.18M | -16.0% |
| Total current assets | $264.69M | $259.05M | $246.68M | $271.17M | $289.65M | +2.2% |
| Property, plant & equipment | $165.00K | $178.00K | $4.16M | $5.01M | $5.88M | -7.3% |
| Goodwill & intangibles | $56.95M | $61.09M | $66.07M | $74.56M | $84.03M | -6.8% |
| Total assets | $327.18M | $325.97M | $323.79M | $359.43M | $388.66M | +0.4% |
| Total current liabilities | $91.26M | $83.77M | $73.21M | $86.49M | $87.92M | +8.9% |
| Total debt | $2.98M | $3.96M | $4.52M | $5.46M | $6.39M | -24.8% |
| Total liabilities | $92.87M | $85.84M | $76.00M | $92.06M | $94.08M | +8.2% |
| Retained earnings | -$2.08B | -$2.07B | -$2.06B | -$2.04B | -$2.00B | -0.5% |
| Shareholder equity | $221.22M | $227.33M | $235.58M | $254.91M | $282.59M | -2.7% |
| Working capital | $173.43M | $175.28M | $173.47M | $184.68M | $201.74M | -1.1% |
| Net tangible assets | $164.27M | $166.24M | $169.51M | $180.35M | $198.56M | -1.2% |
| Shares issued | 16.93M | 16.66M | 16.43M | 16.32M | 16.09M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$9.63M | -$10.30M | -$25.17M | -$31.91M | -$19.53M | — | +6.6% |
| Depreciation & amortisation | $7.01M | $7.59M | $8.49M | $9.44M | $8.22M | — | -7.6% |
| Stock-based compensation | $2.03M | $2.30M | $4.58M | $4.08M | $6.01M | — | -11.8% |
| Change in working capital | $10.26M | $161.00K | -$9.11M | -$3.20M | -$1.76M | — | +6,271.4% |
| Operating cash flow | $10.72M | -$983.00K | -$17.36M | -$18.77M | -$4.72M | — | +1,190.2% |
| Capital expenditure | -$2.86M | -$2.79M | -$12.00K | — | — | -$9.00K | -2.5% |
| Investing cash flow | $4.17M | -$2.79M | -$2.29M | $0 | $0 | — | +249.7% |
| Share buybacks | $0 | $0 | -$1.00K | -$1.00K | -$1.00K | — | — |
| Financing cash flow | $0 | $303.00K | -$1.00K | $299.00K | -$1.00K | — | -100.0% |
| Free cash flow | $7.86M | -$3.77M | -$17.37M | -$18.77M | -$4.72M | — | +308.5% |
| End cash position | $196.74M | $180.00M | $183.12M | $201.68M | $219.87M | — | +9.3% |
Options analytics
Put / call volume
0.17
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
10.00
-18.5% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
+21.9%
Puts bid over calls
Call volume
12
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
10.00
0 contracts
Heaviest put OI
10.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.60 | -0.51 | +14.3% |
| Mar 2026 | -0.77 | -0.67 | +12.9% |
| Dec 2025 | -1.60 | -1.13 | +29.5% |
| Sep 2025 | -1.46 | -1.55 | -6.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.66 | 1 | $47.29M | -16.0% |
| Next quarter | -0.44 | 1 | $49.04M | -11.3% |
| Current year | -2.56 | 1 | $203.15M | -18.5% |
| Next year | -1.58 | 1 | $210.58M | +3.7% |
Analyst targets & ownership
Mean target$12.80
High target$16.00
Low target$11.00
Implied upside4.32%
Analyst count5
ConsensusNONE
Strong buy / Buy0 / 1
Hold6
Sell / Strong sell0 / 0
Held by insiders4.57%
Held by institutions47.60%
Institutions holding79
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
13.05
-5.96% from price
SMA 20
13.17
-6.85% from price
SMA 50
12.57
-2.37% from price
SMA 100
10.93
+12.22% from price
SMA 200
8.19
+49.86% from price
EMA 12
12.94
-5.16% from price
EMA 26
12.89
-4.82% from price
EMA 50
12.36
-0.75% from price
RSI (14)
43.2
Neutral
MACD (12,26,9)
0.05
Hist -0.18
ATR (14)
0.69
5.66% of price
Realised vol 30D
50.7%
Annualised
Bollinger upper
14.12
20, 2σ
Bollinger lower
12.23
20, 2σ
50 / 200 cross
Golden
12.57 vs 8.19
Trend bias
Above 200
+49.86%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.93
Less volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
50.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.9%
Peak to trough
Max drawdown 5Y
-98.0%
Peak to trough
ATR 14
0.69
5.66% of price
Beta (reported)
1.68
5Y monthly, from filing
Short interest
Shares short
160.46K
Prior 159.62K
Change vs prior
+0.5%
Shorts adding
% of float
1.09%
Normal
% of shares out
0.94%
Against total outstanding
Days to cover
1.7
Liquid
Float
11.93M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 5, 26 | Needham | MAINTAINED | Hold | Hold |
| Jul 17, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 6, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| May 6, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 13, 26 | Stifel | MAINTAINED | Hold | Hold |
| Dec 18, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Nov 5, 25 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Nov 5, 25 | Stifel | MAINTAINED | Hold | Hold |
| Aug 7, 25 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 23, 25 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| May 8, 25 | UBS | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:20
Split dateJul 11, 2024
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-07-14
Corporate Changes & Voting Matters
8-K · 2026-06-22
Proxy Statements
DEFA14A · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-05
Annual Report to Shareholders
ARS · 2026-04-23
Headlines
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Zacks · 5d ago
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
Trefis · 13d ago
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Zacks · 21d ago
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Zacks · 21d ago
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Zacks · 23d ago
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
Zacks · 26d ago
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
GlobeNewswire · 29d ago
American Well (AMWL) Stock Sees Fair Value Lift After Higher Analyst Targets
Simply Wall St. · 32d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.